Literature DB >> 9184463

Behaviors as risk factors for rehospitalization: implications for predicting and preventing admissions among the seriously mentally ill.

G Sullivan1, A S Young, H Morgenstern.   

Abstract

This case-control study investigated the extent to which aberrant behaviors, in contrast to more traditional clinical factors (such as symptoms and alcohol abuse), place individuals with schizophrenia at increased risk for rehospitalization. One hundred and one recidivists (cases) were matched to 101 non-recidivists (controls) on gender, race, and time since index hospitalization. Key informants, usually family members, were interviewed to assess behaviors during a 2-week period. After controlling for possible confounding variables, we found that each aberrant behavior increased the risk for rehospitalization, but highly disruptive or dangerous behaviors (such as threatening others, acting very bizarrely, or attempting suicide) conveyed a markedly high degree of risk (adjusted odds ratio = 83.9). It is possible that service providers may be able to avert the fiscal and emotional cost of hospitalization by collaborating more closely with family members to identify these behaviors and intervene before hospitalization becomes unavoidable.

Entities:  

Mesh:

Year:  1997        PMID: 9184463     DOI: 10.1007/BF00788237

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  15 in total

1.  Concordance of multiple assessments of the outcome of schizophrenia. On defining the dependent variable in outcome studies.

Authors:  C C Schwartz; J K Myers; B M Astrachan
Journal:  Arch Gen Psychiatry       Date:  1975-10

2.  Predicting relapse in schizophrenia: the development and implementation of an early signs monitoring system using patients and families as observers, a preliminary investigation.

Authors:  M Birchwood; J Smith; F Macmillan; B Hogg; R Prasad; C Harvey; S Bering
Journal:  Psychol Med       Date:  1989-08       Impact factor: 7.723

3.  Characteristics of community support program clients in 1980 and 1984.

Authors:  V M Mulkern; R W Manderscheid
Journal:  Hosp Community Psychiatry       Date:  1989-02

Review 4.  Family interventions for schizophrenia.

Authors:  L B Dixon; A F Lehman
Journal:  Schizophr Bull       Date:  1995       Impact factor: 9.306

Review 5.  The costs of schizophrenia. Assessing the burden.

Authors:  A Rupp; S J Keith
Journal:  Psychiatr Clin North Am       Date:  1993-06

6.  A heuristic vulnerability/stress model of schizophrenic episodes.

Authors:  K H Nuechterlein; M E Dawson
Journal:  Schizophr Bull       Date:  1984       Impact factor: 9.306

7.  Relapse: a reappraisal of assessment of outcome in schizophrenia.

Authors:  I R Falloon
Journal:  Schizophr Bull       Date:  1984       Impact factor: 9.306

8.  Psychiatric and social reasons for frequent rehospitalization.

Authors:  S Kent; P Yellowlees
Journal:  Hosp Community Psychiatry       Date:  1994-04

9.  Prospective study of prodromal symptoms in schizophrenic relapse.

Authors:  D W Heinrichs; W T Carpenter
Journal:  Am J Psychiatry       Date:  1985-03       Impact factor: 18.112

10.  The de facto US mental and addictive disorders service system. Epidemiologic catchment area prospective 1-year prevalence rates of disorders and services.

Authors:  D A Regier; W E Narrow; D S Rae; R W Manderscheid; B Z Locke; F K Goodwin
Journal:  Arch Gen Psychiatry       Date:  1993-02
View more
  2 in total

1.  Characteristics of individuals with severe mental illness who use emergency services.

Authors:  Alexander S Young; Matthew J Chinman; Julie A Cradock-O'Leary; Greer Sullivan; Dennis Murata; Jim Mintz; Paul Koegel
Journal:  Community Ment Health J       Date:  2005-04

2.  Utilization of specialty mental health care among persons with severe mental illness: the roles of demographics, need, insurance, and risk.

Authors:  D D McAlpine; D Mechanic
Journal:  Health Serv Res       Date:  2000-04       Impact factor: 3.402

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.